Shigeyuki Saitoh Selected Research

Shigeyuki Saitoh Research Topics

Disease

24	Insulin Resistance 05/2022 - 12/2004
18	Hypertension (High Blood Pressure) 05/2022 - 09/2002
9	Obesity 09/2022 - 08/2005
8	Atherosclerosis 05/2022 - 02/2003
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2007
5	Dyslipidemias (Dyslipidemia) 09/2022 - 06/2015
5	Liver Diseases (Liver Disease) 09/2022 - 11/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 03/2005
3	Fatty Liver 09/2022 - 03/2022
3	Diabetes Mellitus 05/2022 - 11/2003
3	Hyperuricemia 09/2021 - 09/2019
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2011
3	Body Weight (Weight, Body) 03/2020 - 01/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 08/2005
3	Hypercholesterolemia 01/2016 - 08/2005
3	Abdominal Obesity 06/2015 - 03/2005
3	Hypertriglyceridemia 03/2007 - 03/2005
2	Non-alcoholic Fatty Liver Disease 09/2022 - 03/2022
2	Stroke (Strokes) 01/2018 - 01/2013
2	Carotid Artery Diseases 01/2018 - 01/2017
2	Neoplasms (Cancer) 09/2016 - 01/2000
2	Prostatic Neoplasms (Prostate Cancer) 09/2016 - 01/2000
2	Type 2 Diabetes Mellitus (MODY) 08/2014 - 05/2008
2	Isolated Systolic Hypertension 11/2012 - 08/2006
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2009 - 12/2007
2	Glucose Intolerance 07/2008 - 01/2007
2	Arteriosclerosis 11/2003 - 09/2002
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Weight Loss (Weight Reduction) 06/2016
1	Myocardial Infarction 01/2016
1	Parkinson Disease (Parkinson's Disease) 07/2015
1	Left Ventricular Dysfunction 08/2014
1	Albuminuria 01/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2009
1	Hyperinsulinism (Hyperinsulinemia) 04/2009

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 02/2003
8	Triglycerides (Triacylglycerol)IBA 09/2022 - 08/2005
8	HDL CholesterolIBA 05/2022 - 08/2005
8	CholesterolIBA 03/2022 - 03/2005
8	Fatty Acid-Binding ProteinsIBA 01/2021 - 01/2014
7	Uric Acid (Urate)IBA 05/2022 - 04/2009
7	Insulin (Novolin)FDA Link 03/2022 - 01/2000
7	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 08/2006
6	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2013
5	AdiponectinIBA 05/2022 - 12/2004
5	HDL LipoproteinsIBA 01/2018 - 03/2005
4	C-Reactive ProteinIBA 11/2021 - 12/2004
4	AdipokinesIBA 01/2021 - 01/2010
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 12/2007
3	Blood Glucose (Blood Sugar)IBA 11/2012 - 02/2003
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 09/2022 - 09/2019
2	IronIBA 09/2022 - 07/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 08/2010
2	fibroblast growth factor 21IBA 03/2022 - 07/2019
2	CreatinineIBA 11/2021 - 05/2008
2	Xanthine DehydrogenaseIBA 09/2021 - 09/2019
2	PotassiumIBA 03/2020 - 01/2016
2	Alanine Transaminase (SGPT)IBA 09/2019 - 01/2018
2	EnzymesIBA 09/2019 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2007
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 01/2011
2	LipidsIBA 02/2012 - 07/2008
2	Angiotensin IIIBA 04/2009 - 12/2006
2	CytokinesIBA 02/2009 - 09/2002
2	Indicators and Reagents (Reagents)IBA 03/2005 - 02/2003
1	Urea (Carbamide)FDA LinkGeneric 09/2022
1	NitrogenIBA 09/2022
1	GlycolipidsIBA 03/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021
1	HypoxanthineIBA 07/2020
1	XanthineIBA 07/2020
1	MicronutrientsIBA 03/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019
1	AntioxidantsIBA 11/2018
1	ORALIT (ORS)IBA 09/2016
1	Hormones (Hormone)IBA 09/2016
1	IsoflavonesIBA 09/2016
1	EquolIBA 09/2016
1	glyciteinIBA 09/2016
1	daidzeinIBA 09/2016
1	GenisteinIBA 09/2016
1	Proprotein Convertase 9IBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	Dietary SodiumIBA 01/2016
1	alpha-SynucleinIBA 07/2015
1	SaltsIBA 12/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013
1	LDL CholesterolIBA 11/2012
1	VLDL LipoproteinsIBA 01/2011
1	Lipoproteins (Lipoprotein)IBA 01/2011
1	oxidized low density lipoproteinIBA 01/2011
1	lipoprotein cholesterolIBA 05/2010
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2010
1	Lamin Type A (Lamin A)IBA 08/2009
1	Biological ProductsIBA 04/2009

Therapy/Procedure

2	Therapeutics 02/2013 - 02/2009
1	Secondary Prevention 01/2019
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 06/2016
1	Glycemic Control 08/2014